Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma PopulationWaleed Alduaij, David W. Scott, Barbara Meissner et al.|Blood|2022Cited by 89
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphomaNicole Thomas, Stefania Pittaluga, Kostiantyn Dreval et al.|Blood|2022Cited by 86
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K. Hilton, David W. Scott, Henry S. Ngu et al.|Journal of Clinical Oncology|2023Cited by 50